JP2021512876A5 - - Google Patents
Info
- Publication number
- JP2021512876A5 JP2021512876A5 JP2020542141A JP2020542141A JP2021512876A5 JP 2021512876 A5 JP2021512876 A5 JP 2021512876A5 JP 2020542141 A JP2020542141 A JP 2020542141A JP 2020542141 A JP2020542141 A JP 2020542141A JP 2021512876 A5 JP2021512876 A5 JP 2021512876A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- lipoic
- furoic
- pharmaceutically acceptable
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841004306 | 2018-02-05 | ||
| IN201841004306 | 2018-02-05 | ||
| IN201841008091 | 2018-03-05 | ||
| IN201841008091 | 2018-03-05 | ||
| PCT/IB2019/050901 WO2019150341A1 (en) | 2018-02-05 | 2019-02-05 | Combination of an antimuscarinic or an anticholinergic agent and lipoic acid and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512876A JP2021512876A (ja) | 2021-05-20 |
| JP2021512876A5 true JP2021512876A5 (https=) | 2022-02-02 |
| JPWO2019150341A5 JPWO2019150341A5 (https=) | 2022-02-02 |
Family
ID=67480013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542141A Pending JP2021512876A (ja) | 2018-02-05 | 2019-02-05 | 抗ムスカリン薬又は抗コリン作動薬及びリポ酸の組合せ物並びにその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20200375961A1 (https=) |
| EP (1) | EP3749303A4 (https=) |
| JP (1) | JP2021512876A (https=) |
| KR (1) | KR20200118128A (https=) |
| AU (1) | AU2019214557A1 (https=) |
| BR (1) | BR112020015436A2 (https=) |
| CA (1) | CA3089894A1 (https=) |
| IL (1) | IL276350A (https=) |
| MX (1) | MX2020008173A (https=) |
| RU (1) | RU2020122659A (https=) |
| SG (1) | SG11202006492SA (https=) |
| WO (1) | WO2019150341A1 (https=) |
| ZA (1) | ZA202004058B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3522873B1 (en) * | 2016-10-04 | 2022-03-16 | Cellix Bio Private Limited | Compositions and methods for the treatment of xerostomia |
| CA3116589A1 (en) | 2018-10-26 | 2020-04-30 | Ocuphire Pharma, Inc. | Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders |
| WO2020144546A1 (en) * | 2019-01-12 | 2020-07-16 | Cellix Bio Private Limited | Combination of selective alpha-adrenergic receptor agonist or an anticholinergic agent and lipoic acid and uses thereof |
| CN113387923A (zh) * | 2020-03-13 | 2021-09-14 | 诺华股份有限公司 | 硫辛酸胆碱酯盐的药物组合物及使用其的治疗方法 |
| IL298476A (en) * | 2020-05-26 | 2023-01-01 | Cellix Bio Private Ltd | Pharmaceutical formulations of pilocarpine r-(+)-lipoate |
| WO2022080529A1 (ko) * | 2020-10-15 | 2022-04-21 | 경상대학교병원 | 침분비 저하증 예방 또는 치료용 약학적 조성물 및 건강기능식품 |
| WO2023052977A1 (en) * | 2021-09-29 | 2023-04-06 | Avaca Pharma Private Limited | Compositions, methods and uses thereof |
| WO2023052974A1 (en) * | 2021-09-29 | 2023-04-06 | Avaca Pharma Private Limited | Ocular compositions and methods for the treatment of ophthalmic diseases and disorders |
| CN119454701A (zh) * | 2022-01-18 | 2025-02-18 | 苏州普乐康医药科技有限公司 | 一种含西维美林的眼用制剂及其制备方法和应用 |
| EP4469047A4 (en) * | 2022-01-25 | 2026-03-04 | Biotheravision Inc | AQUEOUS COMPOSITIONS OF CEVIMELINE AND METHODS OF USE |
| WO2023143575A1 (zh) * | 2022-01-29 | 2023-08-03 | 南京济群医药科技股份有限公司 | 一种m-胆碱受体激动剂化合物及其制备方法和用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3608073A (en) * | 1968-07-16 | 1971-09-21 | Barnes Hind Pharm Inc | Emulsion of pilocarpine for ophthalmic use |
| CN1960735B (zh) * | 2004-05-20 | 2015-07-29 | 代阿麦迪卡股份有限公司 | 药物组合在治疗胰岛素抗性中的应用 |
| JP2006070027A (ja) * | 2004-08-06 | 2006-03-16 | Dai Ichi Seiyaku Co Ltd | 口腔粘膜投与剤 |
| US20110150974A1 (en) * | 2004-08-06 | 2011-06-23 | Daiichi Pharmaceutical Co., Ltd. | Agent For Oral Mucosal Administration |
| WO2007064755A2 (en) * | 2005-11-30 | 2007-06-07 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
| UA86441C2 (ru) * | 2007-03-30 | 2009-04-27 | Акционерное Общество Открытого Типа "Галичфарм" | (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе |
| US20090263467A1 (en) * | 2008-04-21 | 2009-10-22 | Hemant Narahar Joshi | Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments |
| EP2821405B1 (en) * | 2009-06-15 | 2016-04-13 | Encore Health, LLC | Choline esters for treating presbyopia and cataract |
| JP5595513B2 (ja) * | 2009-11-12 | 2014-09-24 | アカシア ファーマ リミテッド | 口腔乾燥症の治療のためのベタネコールの使用 |
| US10507245B2 (en) * | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
| JP2015533174A (ja) * | 2012-10-11 | 2015-11-19 | セラヴィダ，インコーポレイテッド | ピロカルピンの医薬製剤 |
| KR101586789B1 (ko) * | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| US9427144B2 (en) * | 2014-01-03 | 2016-08-30 | Ophthalmx Llc | Methods and systems for detecting ophthalmic disease |
| CA2936146A1 (en) * | 2014-01-06 | 2015-07-09 | Stealth Biotherapeutics Corp | Methods and compositions for preventing or treating dominant optic atrophy |
| EP3522873B1 (en) * | 2016-10-04 | 2022-03-16 | Cellix Bio Private Limited | Compositions and methods for the treatment of xerostomia |
| CA3081553C (en) * | 2017-11-17 | 2022-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of eye disorders |
| WO2020144546A1 (en) * | 2019-01-12 | 2020-07-16 | Cellix Bio Private Limited | Combination of selective alpha-adrenergic receptor agonist or an anticholinergic agent and lipoic acid and uses thereof |
-
2019
- 2019-02-05 BR BR112020015436-9A patent/BR112020015436A2/pt not_active Application Discontinuation
- 2019-02-05 RU RU2020122659A patent/RU2020122659A/ru unknown
- 2019-02-05 SG SG11202006492SA patent/SG11202006492SA/en unknown
- 2019-02-05 WO PCT/IB2019/050901 patent/WO2019150341A1/en not_active Ceased
- 2019-02-05 KR KR1020207025451A patent/KR20200118128A/ko not_active Ceased
- 2019-02-05 MX MX2020008173A patent/MX2020008173A/es unknown
- 2019-02-05 AU AU2019214557A patent/AU2019214557A1/en not_active Abandoned
- 2019-02-05 CA CA3089894A patent/CA3089894A1/en active Pending
- 2019-02-05 EP EP19747106.3A patent/EP3749303A4/en not_active Withdrawn
- 2019-02-05 JP JP2020542141A patent/JP2021512876A/ja active Pending
-
2020
- 2020-07-02 ZA ZA2020/04058A patent/ZA202004058B/en unknown
- 2020-07-28 IL IL276350A patent/IL276350A/en unknown
- 2020-08-04 US US16/985,187 patent/US20200375961A1/en not_active Abandoned
-
2022
- 2022-11-23 US US17/993,868 patent/US20230310391A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512876A5 (https=) | ||
| RU2020122659A (ru) | Комбинация антимускаринового или антихолинергического средства и липоевой кислоты и ее применения | |
| JP2004526745A5 (https=) | ||
| AU2012338362B2 (en) | Tricyclic compounds, compositions comprising them and uses thereof | |
| US20160199385A1 (en) | Mineral Amino-Acid Complexes of Active Agents | |
| ES2979262T3 (es) | Composiciones que comprenden metilfenidato-profármacos, procesos de elaboración y uso de las mismas | |
| JP7524411B2 (ja) | 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び／又は治療のための使用 | |
| JP2016534063A5 (https=) | ||
| BRPI0708071A2 (pt) | derivados de catecolamina deuterada e medicamentos compreendendo os ditos compostos | |
| BR112013020424A2 (pt) | Nitrocatecol substituído, utilizações do mesmo, combinação e composição que o compreendem | |
| JPWO2019150341A5 (https=) | ||
| JP2021504398A (ja) | 特異的炎症収束性メディエーターの塩に関連する組成物及び方法 | |
| CN103228618B (zh) | 新化合物及其医药用途 | |
| RU2019113465A (ru) | Композиции и способы лечения ксеростомии | |
| JP2022191331A (ja) | 炎症及び疼痛の治療のための組成物及び方法 | |
| JP2021534160A5 (https=) | ||
| CN112384214A (zh) | 作为可溶性鸟苷酸环化酶激活剂的烷氧基吡唑 | |
| WO2016020919A1 (en) | Compositions comprising tricyclic compounds, and uses thereof | |
| US20170319519A1 (en) | Combination for the treatment of conditions involving muscular pain | |
| JP2020533402A5 (https=) | ||
| JP2016537431A5 (https=) | ||
| ES2272383T3 (es) | Uso de un agente que mejora la funcion astrocitica para el tratamiento de la enfermedad de parkison. | |
| CN109310669B (zh) | 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 | |
| JP2005523269A5 (https=) | ||
| TWI555528B (zh) | 泛醇基二十二碳六烯酸酯及其於治療與預防心血管疾病的用途 |